Glykon Technologies Group

Glykon Technologies Group was a specialty healthcare and biotechnology company focused on the development and commercialization of high-purity carbohydrate-based products for metabolic health. The company's flagship product, Glykon, is a proprietary, pharmaceutical-grade form of Konjac Glucomannan, a natural polysaccharide fiber. Glykon was marketed for its ability to aid in weight management, improve glycemic control in Type 2 diabetes, and reduce LDL cholesterol levels. The company emphasized a specialized scientific purification process to ensure the efficacy and safety of its carbohydrate compounds in clinical applications. Although active in the early 2000s and a member of the Biotechnology Industry Organization (BIO), the company is currently considered inactive.